Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CRTC1P1 (CREB regulated transcription coactivator 1 pseudogene 1) is a **pseudogene** related to the CRTC1 gene, which encodes a transcriptional coactivator involved in regulating gene expression via the CREB pathway[3][5]. Unlike CRTC1, which plays critical roles in cell signaling, neuronal function, and is implicated in diseases such as cancer and Alzheimer's disease[1][3][5], **CRTC1P1 does not code for a functional protein** and is not known to participate in any biological processes or act as a therapeutic target. Pseudogenes such as CRTC1P1 are noncoding DNA sequences that resemble functional genes but have lost their protein-coding ability or regulatory functions due to accumulated mutations. There is no evidence that CRTC1P1 plays any role in disease, drug interaction, or biomarker development. Note: Actual gene and protein function, therapeutic targeting, and disease associations pertain to CRTC1, not CRTC1P1. Queries or data referring to CRTC1P1 as a potential molecular target are incorrect[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CREB regulated transcription coactivator 1 pseudogene 1 (CRTC1P1).